Potential public health and economic impact of maternal vaccination with bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine for the prevention of acute respiratory infection among infants in the United States

Potential public health and economic impact of maternal vaccination with bivalent respiratory syncytial virus prefusion F (RSVpreF) vaccine for the prevention of acute respiratory infection among infants in the United States

Background The U.S. Advisory Committee on Immunization Practices recommends use of bivalent stabilized prefusion F subunit vaccine (RSVpreF) among pregnant persons to protect their infants against lower respiratory tract illness due to RSV (RSV-LRTI).Research design and methods Using a cohort model...

Full description

Saved in:
Bibliographic Details
Main Authors: Ahuva Averin, Amy W. Law, Derek Weycker, Mark Atwood, Erin Quinn, Jessica E. Atwell, Alejandro Cane, Bradford D. Gessner, Sarah Pugh, Kimberly M. Shea
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Expert Review of Vaccines
Subjects:
Costs and cost analysis
infants
maternally acquired immunity
public health
respiratory syncytial virus
respiratory syncytial virus vaccine
Online Access:https://www.tandfonline.com/doi/10.1080/14760584.2025.2503966
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.tandfonline.com/doi/10.1080/14760584.2025.2503966

Similar Items